Jeff Yass’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15,700
| Closed | -$179K | – | 13326 |
|
|
2026
Q1 | $179K | Sell |
15,700
-1,700
| -10% | -$18.4K | ﹤0.01% | 11815 |
|
|
2025
Q4 | $223K | Sell |
17,400
-33,700
| -66% | -$416K | ﹤0.01% | 10631 |
|
|
2025
Q3 | $571K | Buy |
51,100
+38,300
| +299% | +$370K | ﹤0.01% | 8668 |
|
|
2025
Q2 | $127K | Buy |
+12,800
| New | +$125K | ﹤0.01% | 11630 |
|
|
2020
Q4 | – | Sell |
-12,900
| Closed | -$156K | – | 10968 |
|
|
2020
Q3 | $156K | Buy |
+12,900
| New | +$122K | ﹤0.01% | 9651 |
|
|
2020
Q2 | – | Sell |
-14,300
| Closed | -$149K | – | 10065 |
|
|
2020
Q1 | $149K | Buy |
+14,300
| New | +$180K | ﹤0.01% | 8997 |
|
|
2019
Q4 | – | Sell |
-11,200
| Closed | -$206K | – | 9648 |
|
|
2019
Q3 | $206K | Sell |
11,200
-700
| -6% | -$13.7K | ﹤0.01% | 9032 |
|
|
2019
Q2 | $234K | Buy |
11,900
+500
| +4% | +$10.2K | ﹤0.01% | 8817 |
|
|
2019
Q1 | $261K | Buy |
+11,400
| New | +$247K | ﹤0.01% | 7457 |
|
|
2017
Q4 | – | Sell |
-14,200
| Closed | -$243K | – | 9178 |
|
|
2017
Q3 | $243K | Sell |
14,200
-5,500
| -28% | -$92.4K | ﹤0.01% | 7723 |
|
|
2017
Q2 | $319K | Buy |
19,700
+2,200
| +13% | +$34.8K | ﹤0.01% | 7477 |
|
|
2017
Q1 | $304K | Sell |
17,500
-600
| -3% | -$10K | ﹤0.01% | 7313 |
|
|
2016
Q4 | $305K | Sell |
18,100
-2,000
| -10% | -$33.4K | ﹤0.01% | 7941 |
|
|
2016
Q3 | $353K | Buy |
20,100
+1,400
| +7% | +$22.7K | ﹤0.01% | 6657 |
|
|
2016
Q2 | $269K | Sell |
18,700
-8,800
| -32% | -$110K | ﹤0.01% | 7131 |
|
|
2016
Q1 | $338K | Sell |
27,500
-5,700
| -17% | -$63K | ﹤0.01% | 7072 |
|
|
2015
Q4 | $403K | Buy |
33,200
+8,000
| +32% | +$98.5K | ﹤0.01% | 7165 |
|
|
2015
Q3 | $332K | Sell |
25,200
-31,300
| -55% | -$473K | ﹤0.01% | 7864 |
|
|
2015
Q2 | $927K | Sell |
56,500
-800
| -1% | -$13.3K | ﹤0.01% | 6375 |
|
|
2015
Q1 | $1.02M | Buy |
57,300
+20,100
| +54% | +$374K | ﹤0.01% | 5731 |
|
|
2014
Q4 | $707K | Buy |
37,200
+9,400
| +34% | +$159K | ﹤0.01% | 6539 |
|
|
2014
Q3 | $381K | Sell |
27,800
-95,100
| -77% | -$1.36M | ﹤0.01% | 7669 |
|
|
2014
Q2 | $2.01M | Buy |
122,900
+35,300
| +40% | +$511K | ﹤0.01% | 4653 |
|
|
2014
Q1 | $1.38M | Buy |
87,600
+47,000
| +116% | +$766K | ﹤0.01% | 4951 |
|
|
2013
Q4 | $698K | Buy |
+40,600
| New | +$625K | ﹤0.01% | 6146 |
|
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Jeff Yass's ANGO Position: Q2 2026 in Review
Jeff Yass reduced its AngioDynamics (ANGO) stake by 48% in Q2 2026, selling an estimated $114K and leaving 10,647 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #12265.
Jeff Yass first reported a position in ANGO in Q2 2014 and has held it in 29 quarters since. The position peaked at $1.14M in Q4 2023. 160 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Jeff Yass held 10,647 shares of AngioDynamics worth $139K as of Q2 2026.
- Jeff Yass sold 9,999 AngioDynamics shares in Q2 2026, an estimated $114K.
- AngioDynamics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12265 holding.
- Jeff Yass first reported a position in AngioDynamics in Q2 2014 and has held it in 29 quarters since.
- Jeff Yass's AngioDynamics position peaked at $1.14M in Q4 2023.
- 160 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.